Yeh Lab
Located within the UNC Lineberger Comprehensive Cancer Center, the Yeh Lab’s focus is to identify and study novel therapeutic targets for the treatment of pancreatic cancer. Pancreatic cancer in particular continues to be a lethal disease with few therapeutic options. Our research therefore centers on target identification through genomic, and more recently proteomic analyses of patient samples.
Learn More
Research
-
UNC CCBTP T32
Congratulations Maddy Jenner for acceptance into the UNC CCBTP (Cancer Cell Biology Training Program) T32! Maddy is currently a graduate student in Yeh Lab.
-
Joseph Kearney, MD, receives AHPBA 2021 Steve Sotsky Award
Dr. Kearney is a recipient of the Americas Hepato-Pancreato-Biliary Association 2021 Steve Sotsky Award. This annual award recognizes outstanding work in the field of pancreatic research by a trainee.
-
Spring 2021 UNC Lineberger Innovation Award – Dr. Xianlu (Laura) Peng
Dr. Xianlu (Laura) Peng was awarded a Spring 2021 UNC Lineberger Innovation Award, for the project title, “Interrogation of epigenetic disparities in minority population for precision medicine in gastric cancer”.
-
UNC CCBTP T32
Congratulations on Mariaelena Nabors’ acceptance into the UNC CCBTP (Cancer Cell Biology Training Program) T32! Mariaelena is currently a graduate student in Yeh Lab. Mariaelena Nabors
-
Pope Fellowship Award Recipient
Dr. Deborah Weighill, current post-doctoral trainee in Yeh lab, will be funded by the for Pope Fellowship Award for a period of 2 years, effective July 1, 2021. Congratulations!
PANCREATIC CANCER NEWS
- Long noncoding RNA SOX2OT promotes pancreatic cancer cell migration and invasion through destabilizing FUS protein via ubiquitination
- Micronutritional status after pylorus preserving duodenopancreatectomy: analysis of data from a randomized controlled trial
- Acinar cell clonal expansion in pancreas homeostasis and carcinogenesis